Drugs / Anluohuaxian Pill
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03568578 | Jan 2018 → Dec 2020 | fibrotic liver disease, hepatitis B virus infection | Peking University First Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anluohuaxian Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03568578 ↗ |